← All stocks

MoonLake Immunotherapeutics

MLTX Net selling

CIK 0001821586 #2320 in the set updated 17 Sep 2026

Bought (120 mo)

$134.83M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$267.97M

$39.07M on a plan · $1.15M straight out of an exercise

Sold at will

$227.76M

18 of 60 sales

Net

−$133.14M

−$92.93M against sales at will

By person

8 insiders · 100 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

BVF PARTNERS L P/IL entity

Director

—

$162.97M (6)

−$162.97M

1,039,238

$20.78M

−84.7%

Chen Bihua

Former 10% Owner

$130.43M (38)

$46.87M (5)

+$83.57M

2,424,173

$48.48M

+463.8%

Reich Kristian

Chief Scientific Officer

—

$19.54M (24) scheduled

−$19.54M

2,746,587

$54.93M

−19.5%

Santos da Silva Jorge

Chief Executive Officer

—

$19.15M (14) scheduled

−$19.15M

2,774,893

$55.50M

−17.5%

Sturge Simon

Director

—

$9.19M (1)

−$9.19M

171,980

$3.44M

−49.9%

Bodenstedt Matthias

Chief Financial Officer

$98.81K (1)

$9.12M (9) scheduled

−$9.02M

1,115,435

$22.31M

+21.9%

Helix Holdings LLC entity

Former 10% Holder

$4.30M (1)

—

+$4.30M

3,215,000

$64.30M

—

Moukheibir Catherine

Director

—

$1.15M (1) scheduled

−$1.15M

$0.00

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 81

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 9

Sales on a Rule 10b5-1 plan 41

Sales straight out of an exercise 1

Sales at will 18

Transactions with no price 0

Shares from compensation/vesting 22,111,514

History held since 22 Oct 2020